It’s a kind of control that no one has ever tried before in patients,” Tune’s chief scientific officer said Monday.

In a bumper week for new biotech financings, debutante Kardigan ruled the roost with a $300 million first round that will ...

N-Power Medicine, backed by Merck GHI, announced the acquisition of Syapse Holdings. Samsung Biologics and LigaChem extended their ADC services deal. Publicis Worldwide merged with Leo Burnett to form ...

Umoja Biopharma announced a $100 million Series C round that will help the Seattle-based company further develop its CAR ...

From the Holderness Family to Grandma C, social media personalities around Raleigh and Durham explain what will get lost if ...

Caidya, a clinical research organization (CRO) based in Raleigh, has raised $165 million in private equity to support its growth.

Tune Therapeutics shared a major milestone this week as the Durham startup raised $175 million to fund its first clinical trial. Born at Duke University, Tune has developed a new epigenome editor ...

Apple TV's most anticipated show, Severance, is finally back with its Season 2 after a long wait of three years, and the premiere has raised more questions about the nature of the Macrodata Refinement ...

GlobalData analysts are predicting an Alzheimer’s disease market boom, tipping its value across major regions to increase ...